2025 年 6 月 18 日，吉利德科学公司（Gilead Sciences）宣布其研发的长效 HIV-1 疗法来那帕韦（lenacapavir）喜获新适应症批准，正式用于 HIV ...

在美国FDA批准吉利德科学 (GILD.US)突破性长效HIV疗法后，高盛发布研报，维持葛兰素史克 (GSK.US)“中性”评级，目标价42美元。高盛认为，此次获批证实了一个已知的竞争风险，因此预计对股价的影响有限。

临床试验显示， 该药对 HIV 感染的阻断率接近 100% ，远超现有每日口服药物 Truvada（需严格每日服用）。吉利德科学（Gilead Sciences）公司首席执行官丹尼尔・奥戴（Daniel O'Day）称，这是“HIV 防治史上的里程碑 ...

当地时间6月18日，吉利德宣布，美国FDA已批准该公司HIV-1衣壳抑制剂Yeztugo（lenacapavir，来那帕韦）上市，作为暴露前预防用于降低成人和体重至少35公斤青少年经性传播感染HIV（艾滋病毒）的风险。这是美国FDA批准的首个一年仅需给药两次的HIV预防药物。试验数据显示，在3期PURPOSE 1和PURPOSE ...

Due to the Group’s strategic relationship with the Geely Group, it has co-developed its purpose-built vehicles and deployed them at scale, with a fleet of over 34,000 purpose-built vehicles across 31 ...

吉利德科学（Gilead ...

MANILA, June 18 (Xinhua) -- Three people were killed and five others injured in a vehicle accident in Tagaytay City in Cavite province, south of Manila, local police said Wednesday. The police said ...

BEIJING, June 18 (Xinhua) -- At Robot World, a robotics exhibition center in southern Beijing, several embodied artificial intelligence (AI) robots deftly perform complex, real-life tasks ranging from ...

吴说获悉，加拿大 Purpose Investments 宣布其 Purpose XRP ETF 已获安大略证券委员会（OSC）最终招募说明书回执，并将于 6 月 18 日在多伦多证券交易所（TSX）上市，交易代码为 XRPP。该 ETF 提供对 XRP 现货资产的直接敞口，是加拿大首批此类产品之一。

Concordia International School Shanghai is set to break ground on a major redevelopment of its Rittmann Center, expanding the iconic facility into a modern, 13,710-square-meter multi-purpose hub desig ...

"Today's students don't just live in the digital world — they shape it," Bjoerklund said. Citing recent data, he noted that ...